Navigation Links
3 Columbia University Medical Center faculty elected to Institute of Medicine
Date:10/9/2007

NEW YORK Three distinguished Columbia University Medical Center faculty have been elected to the Institute of Medicine of the National Academy of Sciences this year.

Election to the Institute of Medicine (IOM) is one of the highest honors in the fields of medicine and health, and Columbia now has 49 members in this esteemed organization. The three CUMC faculty Kathryn Calame, Timothy Pedley and Carolyn Westhoff were among the 65 new IOM members announced Oct. 8, 2007, raising its total active IOM membership to 1,538.

Columbias new members were chosen through a highly selective process that recognizes individuals who have made significant contributions to advancing the medical science, health care, and public health fields, said Lee Goldman, M.D., executive vice president for health and biomedical sciences and dean of the faculties of health and medicine at Columbia University. We are proud to have them in our midst.

Kathryn Calame, Ph.D., is professor of microbiology and of biochemistry & molecular biophysics at Columbias College of Physicians and Surgeons. Dr. Calame studies gene regulation in the immune system, and her laboratory work focuses primarily on transcriptional regulation of lymphocyte development. A major focus of her current work is an unusual transcriptional repressor called Blimp-1 (B lymphocyte induced maturation protein). Her studies on Blimp-1 are revealing important aspects of regulation in both B and T cells.

Timothy A. Pedley, M.D., is the Henry and Lucy Moses Professor of Neurology, chairman of the Department of Neurology at P&S, and neurologist-in-chief at the Neurological Institute at New York-Presbyterian Hospital. Dr. Pedleys clinical and research interests are focused on epilepsy. His laboratory interests are in the role played by the ionic microenvironment in abnormal hippocampal and cortical excitability and in long-lasting changes in the hippocampus induced by repeated seizures.

Carolyn L. Westhoff, M.D., is professor of obstetrics and gynecology at P&S and professor of epidemiology and of population and family health at Columbias Mailman School of Public Health. She studies the effect of obesity on contraceptive effectiveness and leads several research projects investigating contraception and the epidemiology of womens reproductive health. Most recently, Dr. Westhoff was the principal investigator of a clinical trial of a novel oral contraceptive initiation method known as Quick Start.


'/>"/>

Contact: Alex Lyda
mal2133@columbia.edu
212-305-0820
Columbia University Medical Center
Source:Eurekalert

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. Columbia study shows widely used artery clearing device does not help patients during heart attack
3. Columbia scientists develop cancer terminator viruses
4. Contaminants linked to sturgeon decline in Columbia river
5. Columbia University licenses next-generation DNA sequencing technology
6. New bird discovered on unexplored Columbian mountain
7. Columbia scientists determine 3-dimensional structure of cells fuel gauge
8. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
9. New protein discovered by Hebrew University researchers
10. Next Generation Body Scanner Launched By The University Of Manchester
11. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
(Date:6/22/2016)... Research and Markets has announced the addition ... their offering. The global ... billion in 2013. The market is expected to grow at a ... 2020, increasing from $50.6 billion in 2015 to $96.6 billion in ... forecast period (2015 to 2020) are discussed. As well, new products ...
Breaking Biology Technology: